Formulation and evaluation of lipid based taste masked granules of ondansetron HCl

被引:23
作者
Kharb, Vandana [1 ,2 ]
Saharan, Vikas Anand [3 ]
Kharb, Vivek [4 ]
Jadhav, Hemant [5 ]
Purohit, Suresh [6 ]
机构
[1] Jodhpur Natl Univ, Fac Pharmaceut Sci, Jodhpur, Rajasthan, India
[2] ASBASJS, Mem Coll Pharm, Patiala, Punjab, India
[3] Sardar Bhagwan Singh PG Inst Biomed Sci & Res, Dept Pharmaceut Sci, Dehra Dun, Uttar Pradesh, India
[4] Torrent Pharmaceut Ltd, Baddi, Himachal Prades, India
[5] BITS, Pilani, Rajasthan, India
[6] Banaras Hindu Univ, Inst Med Sci, Dept Pharm, Varanasi 221005, Uttar Pradesh, India
关键词
Glycerol monostearate; Digestion; Taste assessment; Release mechanism; CONTROLLED-RELEASE; BITTER TASTE; 888; ATO; MASKING; DISSOLUTION; MATRIX; TABLETS; MICROSPHERES; OPTIMIZATION; STABILITY;
D O I
10.1016/j.ejps.2014.05.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction and aim: Various taste masking approaches comprising the excipients which delay the reach of the drug to taste buds are reported. Lipidic substances can act as release retarding agent and provides a matrix base responsible for suppressing the bitter taste of drug. This work was aimed to study the influence of different proportions of a lipid carrier on the inhibition of bitterness of the drug vis-a-vis in vitro release of drug from the granules. Methods: The lipid-matrix granules of ondansetron HCl with Geleol pellets (glycerol monostearate) were obtained by manual hot melt fusion technique. The prepared granules were characterized by SEM, DSC and XRD. The taste assessment of prepared granules was done by in vitro method based on drug release. Results: Distribution of drug inside the lipid-matrix granules was not properly analyzed by DSC and XRD, moreover these studies revealed no interaction between the drug and lipid. The dissolution tests displayed the significant retardation of drug release from the granules compared to pure drug and additionally indicated the attainment of matrix system via appearance of unbroken granules during in vitro testing. Higuchi relationship for drug release was obtained by drug release kinetics, which also revealed the functioning drug release mechanism, as diffusion controlled but the addition of hydrophilic substance (Cab-o-sil) has changed the mechanism of drug release. Conclusion: The proportions of Geleol and Cab-o-sil taken in granules had affected the dissolution profile. Higher amount of GE resulted in high taste masking ability. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:180 / 188
页数:9
相关论文
共 52 条
[1]   Development of hot melt coating methods [J].
Achanta, AS ;
Adusumilli, PS ;
James, KW ;
Rhodes, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (05) :441-449
[2]   Effect of Aerosil® on the properties of lipid controlled release microparticles [J].
Albertini, B ;
Passerini, N ;
González-Rodríguez, ML ;
Perissutti, B ;
Rodriguez, L .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (02) :233-246
[3]   Kinetics and mechanism of release from glyceryl monostearate-based implants: Evaluation of release in a gel simulating in vivo implantation [J].
Allababidi, S ;
Shah, JC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (06) :738-744
[4]   The latest trends in the taste assessment of pharmaceuticals [J].
Anand, Vikas ;
Kataria, Mahesh ;
Kukkar, Vipin ;
Saharan, Vandana ;
Choudhury, Pratim Kumar .
DRUG DISCOVERY TODAY, 2007, 12 (5-6) :257-265
[5]  
Anand V, 2008, PAK J PHARM SCI, V21, P438
[6]  
[Anonymous], UNTR FUM SIL CAB O S
[7]   Compritol® 888 ATO:: an innovative hot-melt coating agent for prolonged-release drug formulations [J].
Barthelemy, P ;
Laforêt, JP ;
Farah, N ;
Joachim, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (01) :87-90
[8]   Taste Masking by Spray-Drying Technique [J].
Bora, Divyakumar ;
Borude, Priyanka ;
Bhise, Kiran .
AAPS PHARMSCITECH, 2008, 9 (04) :1159-1164
[9]   Pediatric drug formulations of sodium benzoate: II. Coated granules with a lipophilic binder [J].
Breitkreutz, J ;
El-Saleh, F ;
Kiera, C ;
Kleinebudde, P ;
Wiedey, W .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (02) :255-260
[10]  
CHAU TL, 1991, Patent No. 0458751